NextCure Stock Options

NXTC Stock  USD 5.84  0.09  1.57%   
NextCure's latest option contracts expiring on 2025-12-19 have a put-to-call open interest ratio of 0.0 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on December 19th 2025. The NextCure option chain provides detailed quote and price information for the current NextCure option contracts. It shows all of NextCure's listed puts, calls, expiration dates, strike prices, and other pricing information.

In The Money vs. Out of Money Option Contracts on NextCure

Analyzing NextCure's in-the-money options over time can help investors to take a profitable long position in NextCure regardless of its overall volatility. This is especially true when NextCure's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money NextCure's options could be used as guardians of the underlying stock as they move almost dollar for dollar with NextCure's stock while costing only a fraction of its price.
NextCure's stock options are financial instruments that give investors the right to buy or sell shares of NextCure common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell NextCure stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If NextCure's stock price goes up or down, the stock options follow.
The current year's Liabilities And Stockholders Equity is expected to grow to about 146.5 M, whereas Total Stockholder Equity is forecasted to decline to about 62.2 M.

NextCure Current Options Market Mood

NextCure's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps NextCure Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Unfortunately, most NextCure's options investors are not very successful. NextCure's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current NextCure contract

Base on the Rule 16, the options market is currently suggesting that NextCure will have an average daily up or down price movement of about 0.0% per day over the life of the 2025-12-19 option contract. With NextCure trading at USD 5.84, that is roughly USD 0.0. If you think that the market is fully incorporating NextCure's daily price movement you should consider buying NextCure options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing NextCure options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" NextCure calls. Remember, the seller must deliver NextCure stock to the call owner when a call is exercised.

NextCure Option Chain

When NextCure's strike price is surpassing the current stock price, the option contract against NextCure stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
NextCure's option chain is a display of a range of information that helps investors for ways to trade options on NextCure. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for NextCure. It also shows strike prices and maturity days for a NextCure against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
NXTC251219C0000750007.50.0 - 4.94.9Out
Call
NXTC251219C0000500005.00.0 - 4.94.9Out
Call
NXTC251219C0000250032.50.0 - 4.90.05Out
 Put
NXTC251219P0000750007.54.5 - 7.54.5In
 Put
NXTC251219P0000500005.02.0 - 5.02.0In
 Put
NXTC251219P0000250002.50.0 - 2.52.5In

NextCure Market Cap Over Time

   Market Cap   
       Timeline  

NextCure Total Stockholder Equity

Total Stockholder Equity

62.2 Million

At present, NextCure's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

NextCure Corporate Management

CPA CPAChief OfficerProfile
Steven CPAChief OfficerProfile
Sebastien MalovesteSenior DevelopmentProfile
Sourav KunduSenior ManufacturingProfile
Kevin ShawGeneral CounselProfile
Michael MSBACEO, CoFounderProfile
Lieping MDCoFounder BoardProfile
When determining whether NextCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NextCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nextcure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nextcure Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NextCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NextCure. If investors know NextCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NextCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(25.97)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.53)
Return On Equity
(1.06)
The market value of NextCure is measured differently than its book value, which is the value of NextCure that is recorded on the company's balance sheet. Investors also form their own opinion of NextCure's value that differs from its market value or its book value, called intrinsic value, which is NextCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NextCure's market value can be influenced by many factors that don't directly affect NextCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NextCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if NextCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NextCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.